The U.S. Preventive Services Task Force (USPSTF) suggested clinicians continue to offer intensive, multicomponent behavioral interventions for adults with obesity in an updated recommendation statement published Sept. 18 in JAMA.

The direct oral anticoagulant (DOAC) edoxaban is superior to warfarin for mitigating stroke risk in Latin American patients with atrial fibrillation (AFib), according to results of the ENGAGE AF-TIMI trial.

About 14 percent of older adults hospitalized for common, non-cardiac conditions were discharged with more intensive blood pressure medication, according to an analysis published in The BMJ. The concerning part: More than half of those patients actually demonstrated good blood pressure (BP) control in an outpatient setting, suggesting overtreatment from hospital physicians.

Extensive exposure to air pollutants like nitrogen dioxide and fine particulate matter could feed the development of type 2 diabetes (T2D), Chinese researchers reported in a meta-analysis published this month in the European Journal of Endocrinology.

The prevalence of acute myocardial infarction (AMI) in the heart transplant (HT) population is “very low,” according to research published in the current online edition of the American Journal of Cardiology, but HT patients who do suffer a heart attack are more likely to experience longer hospital stays, higher 30-day readmission rates and greater in-hospital morbidities.

A Journal of the American College of Cardiology study this week linked long-term alcohol consumption to adverse cardiac remodeling in patients who were initially young and healthy—something the paper’s authors said might be offset by drinking predominantly wine.

Half of patients who receive percutaneous coronary intervention (PCI) at Veterans Affairs (VA) hospitals in the U.S. travel more than 48 miles for the procedure; a quarter travel at least 110 miles. Yet distance to the PCI site doesn’t significantly influence one-year outcomes, a recent study found.

The FDA has approved Contego Medical’s Paladain Carotid PTA Balloon System, the first approved embolic protection device to contain both a carotid angioplasty balloon and an integrated filter.